JP4772354B2 - Life extension agent made from rice - Google Patents
Life extension agent made from rice Download PDFInfo
- Publication number
- JP4772354B2 JP4772354B2 JP2005095222A JP2005095222A JP4772354B2 JP 4772354 B2 JP4772354 B2 JP 4772354B2 JP 2005095222 A JP2005095222 A JP 2005095222A JP 2005095222 A JP2005095222 A JP 2005095222A JP 4772354 B2 JP4772354 B2 JP 4772354B2
- Authority
- JP
- Japan
- Prior art keywords
- rice
- skin
- cell damage
- ethanol
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims description 75
- 235000009566 rice Nutrition 0.000 title claims description 74
- 240000007594 Oryza sativa Species 0.000 title description 73
- 108090000790 Enzymes Proteins 0.000 claims description 47
- 102000004190 Enzymes Human genes 0.000 claims description 47
- 210000004027 cell Anatomy 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000003795 chemical substances by application Substances 0.000 claims description 31
- 238000000605 extraction Methods 0.000 claims description 17
- 238000000855 fermentation Methods 0.000 claims description 16
- 230000004151 fermentation Effects 0.000 claims description 16
- 239000004480 active ingredient Substances 0.000 claims description 12
- 208000037887 cell injury Diseases 0.000 claims description 10
- 230000005779 cell damage Effects 0.000 claims description 9
- 210000002919 epithelial cell Anatomy 0.000 claims description 7
- 210000002249 digestive system Anatomy 0.000 claims description 5
- 230000002496 gastric effect Effects 0.000 claims description 5
- 230000003625 amylolytic effect Effects 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 230000008439 repair process Effects 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 claims description 2
- 241000209094 Oryza Species 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 1
- 229940100486 rice starch Drugs 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 45
- 230000002265 prevention Effects 0.000 description 32
- 210000000056 organ Anatomy 0.000 description 27
- 230000006872 improvement Effects 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 230000000593 degrading effect Effects 0.000 description 22
- 210000003491 skin Anatomy 0.000 description 22
- 230000000694 effects Effects 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 235000021329 brown rice Nutrition 0.000 description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 230000032683 aging Effects 0.000 description 11
- 208000035475 disorder Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 230000006866 deterioration Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000002366 lipolytic effect Effects 0.000 description 7
- 238000010606 normalization Methods 0.000 description 7
- 229920001277 pectin Polymers 0.000 description 7
- 235000010987 pectin Nutrition 0.000 description 7
- 239000001814 pectin Substances 0.000 description 7
- 230000003716 rejuvenation Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000035784 germination Effects 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 208000017520 skin disease Diseases 0.000 description 6
- 108091035539 telomere Proteins 0.000 description 6
- 210000003411 telomere Anatomy 0.000 description 6
- 102000055501 telomere Human genes 0.000 description 6
- 241000219051 Fagopyrum Species 0.000 description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000007515 enzymatic degradation Effects 0.000 description 5
- 230000003779 hair growth Effects 0.000 description 5
- 210000003041 ligament Anatomy 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 206010062767 Hypophysitis Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 210000004100 adrenal gland Anatomy 0.000 description 4
- 210000000013 bile duct Anatomy 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 230000032823 cell division Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000037336 dry skin Effects 0.000 description 4
- 210000000750 endocrine system Anatomy 0.000 description 4
- 210000003238 esophagus Anatomy 0.000 description 4
- 210000001752 female genitalia Anatomy 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000000777 hematopoietic system Anatomy 0.000 description 4
- 206010021198 ichthyosis Diseases 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000000867 larynx Anatomy 0.000 description 4
- 210000000088 lip Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000005210 lymphoid organ Anatomy 0.000 description 4
- 210000003563 lymphoid tissue Anatomy 0.000 description 4
- 210000000260 male genitalia Anatomy 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 210000002741 palatine tonsil Anatomy 0.000 description 4
- 210000000578 peripheral nerve Anatomy 0.000 description 4
- 210000003800 pharynx Anatomy 0.000 description 4
- 210000004560 pineal gland Anatomy 0.000 description 4
- 210000003635 pituitary gland Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 210000000515 tooth Anatomy 0.000 description 4
- 210000003437 trachea Anatomy 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- 230000002485 urinary effect Effects 0.000 description 4
- 210000001635 urinary tract Anatomy 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 206010014190 Eczema asteatotic Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 240000005926 Hamelia patens Species 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 201000008197 Laryngitis Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004210 Pressure Ulcer Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010048218 Xeroderma Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 208000027993 eye symptom Diseases 0.000 description 2
- -1 face wash Substances 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 239000000162 organ preservation solution Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003761 preservation solution Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010039083 rhinitis Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000046 skin rash Toxicity 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 208000003265 stomatitis Diseases 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 241000722713 Carcharodon carcharias Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 240000002582 Oryza sativa Indica Group Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000006266 hibernation Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000007371 visceral function Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Description
本発明は、米由来成分を有効成分とする、生命体や細胞の寿命延長剤(不死化剤)に関
するものである。
The present invention relates to a life extension agent (immortalizing agent) for life forms and cells, which contains a rice-derived component as an active ingredient.
生命体や細胞の不死化に関しては、テロメアの存在が知られている。テロメアとは、細
胞中にあるDNAの両端に存在する特殊な部分であり、細胞分裂の度に短くなって老化具
合を刻み込むよう機能している。このテロメアの長さを維持する特殊な酵素が、テロメア
ーゼといわれる酵素であり、ガン細胞は、このテロメアーゼによりテロメアの長さが維持
され、永続的な分裂能力を獲得し、不死化を達成している。同様に、このテロメアに係る
DNAの短縮化をビタミンCが抑制することも知られている。
Regarding the immortalization of living organisms and cells, the existence of telomeres is known. A telomere is a special part that exists at both ends of DNA in a cell, and functions so as to be shortened at each cell division and carve out aging. A special enzyme that maintains the length of telomeres is called an enzyme called telomerase. Cancer cells maintain their telomere length, acquire permanent division ability, and achieve immortalization. Yes. Similarly, it is also known that vitamin C suppresses the shortening of DNA related to telomeres.
しかしながら、前記の不死化は、あくまで細胞分裂を繰り返しても、テロメアが削られ
ていくことを防ぐことにより、細胞分裂前のDNAと細胞分裂後のDNAを実質的に同じ
状態に保つというものであり、生命体や細胞それ自体の寿命が延びる訳ではない。
そこで本発明は、無限の複製能の獲得という意味での不死化ではなく、生命体や細胞そ
れ自体の寿命が延びるという意味での不死化(寿命延長)に有効な新規成分を見出すこと
を目的とする。
Therefore, the present invention aims to find a novel component effective for immortalization (life extension) in the sense that the lifespan of living organisms and cells themselves is extended, not immortalization in the sense of acquiring infinite replication ability. And
本発明者らは、動植物合和すの観点から、主食である米を中心に種々の植物成分の研究
を進めてきた。その過程で、米には今まで予測できなかった数多くの可能性および効果が
あることが判明してきた。そこで、主食として用いられ、安全性が最も高いことが実証さ
れている米をテーマとして取り上げ、米の総合利用研究を行ってきた。そのうちの一つの
テーマとして、寿命延長について鋭意研究を重ねてきたのであるが、その過程で、米には
寿命延長効果を有する成分が含有されていることを見出し、本発明を完成するに至った。
The inventors of the present invention have been researching various plant components, mainly rice, which is a staple food, from the viewpoint of combining plants and animals. In the process, it has been found that rice has many possibilities and benefits that could not have been predicted before. Therefore, we have taken up the theme of rice, which is used as a staple food and has proven to be the safest, and has conducted comprehensive rice research. As one of the themes, we have conducted intensive research on life extension. In the process, we found that rice contains ingredients that have a life extension effect, and completed the present invention. .
本発明において、米由来のどのような成分(又は複数の成分の組み合わせ、或いは所定
存在比での複数の成分の組み合わせ)が寿命延長効果を有するのかに関しては、未だ解明
するに至っていないが、米を原料として所定の処理を施したものは、寿命延長効果を示す
ことが判明した。また、寿命延長の作用機序も明らかでないが、生存するに厳しい状況で
は、細胞周期を止めるか細胞活性を下げるかして(遺伝子レベルで調整していることもあ
りうる)一旦休眠し、環境がよくなればこれらを復活させるという、いわゆる「冬眠説」
が関与しているように思われる。しかも、更に、本発明に係る寿命延長剤が、細胞活性、
細胞周期、遺伝子の機能を正常に調節する、より良い状態に調節する機能を有することも
判明した。
In the present invention, it has not yet been elucidated as to what kind of component derived from rice (or a combination of a plurality of components or a combination of a plurality of components at a predetermined abundance ratio) has a life extension effect. It has been found that those subjected to a predetermined treatment using as a raw material show a life extension effect. In addition, the mechanism of life extension is not clear, but in situations where it is difficult to survive, the cell cycle is stopped or the cell activity is lowered (it may be adjusted at the gene level), and then the environment is rested. The so-called “hibernation theory” is to revive these if the situation improves
Seems to be involved. Moreover, the life extension agent according to the present invention further comprises cell activity,
It has also been found that it has a function of regulating the cell cycle and gene function normally, and a better state.
即ち、本発明(1)は、米の粉砕物を有効成分として含有する寿命延長剤である。 That is, the present invention (1) is a life extending agent containing rice pulverized material as an active ingredient.
本発明(2)は、米の抽出物を有効成分として含有する寿命延長剤である。 The present invention (2) is a life extending agent containing rice extract as an active ingredient.
本発明(3)は、米の加水物を酵素分解または麹を作用させたものを有効成分として含
有する寿命延長剤である。
This invention (3) is a life extension agent which contains as an active ingredient what hydrolyzed rice, or the thing which made the rice cake act.
本発明(4)は、米を抽出するに当たり、その抽出前、抽出と同時または抽出後に酵素
分解または麹を作用させたものを有効成分として含有する寿命延長剤である。
The present invention (4) is a life extension agent containing, as an active ingredient, a product which has been subjected to enzymatic degradation or koji before, during or after extraction of rice.
本発明(5)は、米の抽出物あるいは酵素分解または麹を作用させたものに、アルコー
ル発酵あるいは有機酸発酵を行ったものを有効成分として含有する寿命延長剤である。
The present invention (5) is a life extension agent containing, as an active ingredient, a product obtained by subjecting an extract of rice or enzymatic degradation or koji to alcohol fermentation or organic acid fermentation.
本発明(6)は、生命体或いは個体、器官、臓器、組織、体液又は細胞などの寿命延長
剤である、前記(1)〜(5)のいずれか一つの寿命延長剤である。
The present invention (6) is the life extension agent according to any one of the above (1) to (5), which is a life extension agent for a living organism or an individual, an organ, an organ, a tissue, a body fluid, or a cell.
本発明(7)は、細胞機能、細胞活性、細胞周期、遺伝子の機能を正常に調節する、若
々しさを保持し老化を防止するための、前記(1)〜(5)のいずれか一つの寿命延長剤
である。
The present invention (7) is any one of the above (1) to (5) for regulating cell function, cell activity, cell cycle, gene function normally, maintaining youthfulness and preventing aging. Is one life-extending agent.
本発明(8)は、生命体或いは個体、器官、臓器、組織、体液又は細胞などの機能の向
上又は改善、正常化、健全化、老化防止、若々しさ保持或いは若返りのための、前記(1
)〜(5)のいずれか一つの寿命延長剤である。
The present invention (8) is for improving or improving the function of a living organism or an individual, an organ, an organ, a tissue, a body fluid, or a cell, normalization, restoration, prevention of aging, maintaining youthfulness, or rejuvenation. 1
) To (5).
本発明(9)は、循環器系(心臓、血管、血液・造血器系)、免疫系(リンパ性組織・
器官、脾臓、胸腺)、皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、胃、小腸
、大腸、肝臓、胆管系、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿器系(腎
臓、尿路)、性殖系(男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、甲状腺、
副腎)、脳、神経系(末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、平衡・聴
覚器、視覚器、各粘膜系、運動器(骨、関節、筋肉、腱、靱帯)などの機能の向上又は改
善、正常化、健全化、老化防止、若々しさ保持或いは若返りのための、前記(1)〜(5
)のいずれか一つの寿命延長剤である。
The present invention (9) relates to the circulatory system (heart, blood vessel, blood / hematopoietic system), immune system (lymphoid tissue /
Organ, spleen, thymus), skin, skin appendages, digestive system (lips, tonsils, teeth, esophagus, stomach, small intestine, large intestine, liver, bile duct, spleen), respiratory system (nose, pharynx, larynx, trachea) , Lung), urinary system (kidney, urinary tract), sexual reproduction system (male genital organ, female genital organ), endocrine system (pituitary gland, pineal gland, thyroid gland)
Adrenal gland), brain, nervous system (peripheral nerve, central nervous system), metabolic system (sugar, lipid, uric acid metabolism), balance / hearing device, visual organ, mucosal system, motor organ (bone, joint, muscle, tendon, ligament) (1) to (5) for improvement or improvement of functions such as), normalization, restoration, prevention of aging, maintenance of youthfulness or rejuvenation
) One of the life-extending agents.
本発明(10)は、生命体或いは個体、器官、臓器、組織、体液又は細胞などにおける
疾患及び諸症状の予防、悪化防止、改善、治療のための、前記(1)〜(5)のいずれか
一つの寿命延長剤である。
The present invention (10) is any one of the above (1) to (5) for preventing, preventing, improving and treating diseases and various symptoms in living organisms or individuals, organs, organs, tissues, body fluids or cells. Is one life extension agent.
本発明(11)は、循環器系(心臓、血管、血液・造血器系)、免疫系(リンパ性組織
・器官、脾臓、胸腺)、皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、胃、小
腸、大腸、肝臓、胆管系、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿器系(
腎臓、尿路)、性殖系(男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、甲状腺
、副腎)、脳、神経系(末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、平衡・
聴覚器、視覚器、各粘膜系、運動器(骨、関節、筋肉、腱、靱帯)などにおける疾患及び
諸症状の予防、悪化防止、改善、治療のための、前記(1)〜(5)のいずれか一つの寿
命延長剤である。
The present invention (11) includes the circulatory system (heart, blood vessel, blood / hematopoietic system), immune system (lymphoid tissue / organ, spleen, thymus), skin, skin appendage, digestive system (lip, tonsil, Teeth, esophagus, stomach, small intestine, large intestine, liver, bile duct system, spleen), respiratory system (nose, pharynx, larynx, trachea, lung), urinary system (
Kidney, urinary tract), sex breeding system (male genital organ, female genital organ), endocrine system (pituitary gland, pineal gland, thyroid gland, adrenal gland), brain, nervous system (peripheral nerve, central nervous system), metabolic system (sugar, lipid) Uric acid metabolism), equilibrium
The above (1) to (5) for prevention, prevention, improvement and treatment of diseases and symptoms in auditory organs, visual organs, mucosal systems, motor organs (bones, joints, muscles, tendons, ligaments), etc. Is one of the life-extending agents.
本発明(12)は、表皮・真皮に起因する皮膚障害、細胞障害、DNA障害、アトピー
性皮膚炎、ドライスキンなどの乾燥性皮膚症状(アトピー皮膚、乾燥・ソゾウ化皮膚、老
化皮膚、魚鱗癬、かさかさ肌、荒れ肌、皮脂欠乏症、乾皮症、乾燥性湿疹、進行性手掌角
皮症、紅斑、硬化・角化、亀裂、鱗屑、紋理、痒み、掻瘢痕)、シミ、ソバカス、掻痒症
、あせも、荒れ性、しもやけ、ひび、あかぎれ、皮膚老化症状(しわ、ハリ・弾力の低下
、たるみ、シミ)、油性肌、ニキビ、色素異常症、紫外線による皮膚障害(シミ、ソバカ
ス)、光炎症、くすみ、黒ずみ、物理・化学的皮膚障害(切り傷、火傷、床ずれ)、水、
石けん、洗剤、界面活性剤、溶媒の使用により引き起こされる皮膚症状、皮膚外用剤など
の医薬品の副作用、生物的皮膚障害(皮膚感染症)、水虫、皮膚炎、湿疹、創傷治癒、育
毛、養毛、発毛、脱毛症の予防、悪化防止、改善、治療のための、前記(1)〜(5)の
いずれか一つの寿命延長剤である。
The present invention (12) relates to skin disorders caused by epidermis / dermis, cell disorders, DNA disorders, atopic dermatitis, dry skin and other dry skin symptoms (atopy skin, dry / sozoform skin, aging skin, ichthyosis) , Bulky skin, rough skin, sebum deficiency, xeroderma, dry eczema, progressive palmar keratosis, erythema, sclerosis / keratinization, cracks, scales, crest, itching, scarring), spots, buckwheat, pruritus, Skin rash, rough skin, tingling, cracks, redheads, skin aging symptoms (wrinkles, reduced elasticity, sagging, spots), oily skin, acne, dyschromia, UV-induced skin damage (spots, freckles), photoinflammation, dullness , Darkening, physical / chemical skin disorders (cuts, burns, bedsores), water,
Skin symptoms caused by the use of soaps, detergents, surfactants, solvents, side effects of pharmaceuticals such as topical skin preparations, biological skin disorders (skin infections), athlete's foot, dermatitis, eczema, wound healing, hair growth, hair restoration The life-extending agent according to any one of (1) to (5) above, for preventing, preventing, improving, and treating hair growth and alopecia.
本発明(13)は、シミ、ソバカス、老人性色素斑の予防、悪化防止、改善、治療のた
めの、前記(1)〜(5)のいずれか一つの寿命延長剤である。
The present invention (13) is the life extension agent according to any one of the above (1) to (5) for preventing, preventing, improving and treating spots, buckwheat and senile pigment spots.
本発明(14)は、各種炎症、感染症、アレルギー、免疫機能障害、粘膜障害、細胞障
害、DNA障害、腫瘍、潰瘍、高脂血症、肥満、糖尿病、動脈硬化、痛風、血圧の健全化
、改善(高血圧、低血圧)、ボケ、痴呆症、鼻炎、喘息、目の諸症状、風邪、血管障害、
うちみ、肩こり、くじき、神経痛、腰痛、リウマチ、痔、疲労回復、産前産後の冷え症、
口内炎、のどの炎症、痛み、咽頭炎、喉頭炎、扁桃炎、歯周炎、歯槽膿漏、歯肉炎、骨粗
鬆症、滋養強壮、虚弱体質、肉体疲労、体力低下、塩害防止、ヘリコバクターピロリ生育
阻止、ストレス、医薬品による副作用の予防、悪化防止、改善、治療のための、前記(1
)〜(5)のいずれか一つの寿命延長剤である。
In the present invention (14), various inflammations, infections, allergies, immune dysfunctions, mucosal disorders, cell disorders, DNA disorders, tumors, ulcers, hyperlipidemia, obesity, diabetes, arteriosclerosis, gout, blood pressure restoration , Improvement (high blood pressure, low blood pressure), blur, dementia, rhinitis, asthma, eye symptoms, cold, vascular disorder,
Uchimi, stiff shoulders, lottery, neuralgia, low back pain, rheumatism, hemorrhoids, recovery from fatigue, coldness before and after childbirth,
Stomatitis, throat inflammation, pain, sore throat, laryngitis, tonsillitis, periodontitis, alveolar pyorrhea, gingivitis, osteoporosis, nourishing tonic, frail constitution, physical fatigue, low physical fitness, salt damage prevention, Helicobacter pylori growth inhibition, For the prevention of stress, side effects caused by pharmaceuticals, prevention of deterioration, improvement, treatment, (1
) To (5).
本発明(15)は、腫瘍の予防、悪化防止、改善、治療が、癌予防、悪化防止、進行抑
制、転移防止、改善、治療である、前記(1)〜(5)のいずれか一つの寿命延長剤であ
る。
The present invention (15) is any one of the above (1) to (5), wherein the tumor prevention, deterioration prevention, improvement and treatment are cancer prevention, deterioration prevention, progression inhibition, metastasis prevention, improvement and treatment. Life extension agent.
本発明(16)は、性機能の向上、改善、正常化、健全化又は老化防止、若々しさ保持
或いは若返りのための、前記(1)〜(5)のいずれか一つの寿命延長剤である。
The present invention (16) is the life extension agent according to any one of the above (1) to (5) for improving, improving, normalizing, improving or preventing aging, maintaining youthfulness or rejuvenating sexual function. is there.
本発明(17)は、生命体或いは個体、器官、臓器、組織、体液又は細胞などの保存、
鮮度保持のための、前記(1)〜(5)のいずれか一つの寿命延長剤である。
The present invention (17) relates to the preservation of living organisms or individuals, organs, organs, tissues, body fluids or cells,
The life extension agent according to any one of the above (1) to (5) for maintaining freshness.
本発明によれば、生命体や細胞の寿命が延長される。したがって、例えば、臓器移植な
どにおける、臓器保存液や細胞保存液等の使用に適する。また、現在は保存期間に限りが
ある血液に適用すれば、その使用可能期間を伸ばすことができる。更には、細胞の若々し
さが保持され、細胞の活性化が改善され、細胞が若返ると共に、ガン予防・治療、内臓機
能向上・改善、シミ予防・治療、皮膚健全化又は育毛といった、生命体や細胞の寿命が延
長されることに基づく効果が期待できる。
According to the present invention, the life span of living organisms and cells is extended. Therefore, for example, it is suitable for use of organ preservation solution, cell preservation solution, etc. in organ transplantation and the like. Moreover, if it is applied to blood that currently has a limited storage period, the usable period can be extended. Furthermore, the youthfulness of cells is maintained, cell activation is improved, cells rejuvenate, and life forms such as cancer prevention / treatment, visceral function improvement / improvement, spot prevention / treatment, skin health or hair growth In addition, an effect based on extending the life of cells can be expected.
また、米は、今まで主食であったため、新規な利用用途はほとんど開発されていなかっ
た。さらに、米は今まで主食とされてきたものであり、安全性も実証されているものであ
る。すなわち、本発明は、非常に優れた寿命延長効果を持っているばかりでなく、安全性
も十分に実証されているものを見出したものであり、さまざまな医薬品、医薬部外品、化
粧品、食品等に利用できる非常に有意義な発明といえる。また、米の過剰生産といわれて
いる現在、新たな米の利用用途を見出したこと、および米のイメージアップによる消費拡
大を図り得ることは、極めて有意義なことである。
In addition, rice has been a staple food so far, and new uses have hardly been developed. Furthermore, rice has been regarded as a staple food so far, and its safety has been proven. In other words, the present invention has been found not only to have a very excellent life extension effect, but also to have a sufficiently demonstrated safety, various pharmaceuticals, quasi drugs, cosmetics, foods It can be said that it is a very significant invention that can be used for the above. In addition, it is extremely meaningful to find new uses for rice, and to increase consumption by improving the image of rice, which is now said to be overproduction of rice.
本発明に係る「米」とは、白米、玄米及び発芽させた米といった米だけでなく、白糠及
び赤糠といった米の一部も含む概念である。但し、白米部分を必須的に含むもの、即ち、
白米、玄米、発芽させた米、白糠を用いることが好適である。ここで、白米及び玄米に関
しては、ジャポニカ,インディカ米を問わず、うるち米、および餅米等の玄米および白米
を指し、品種、種類は問わない。また、白糠及び赤糠とは、一般に、精白時に出てくる9
2%以上の赤糠や92%以下の白糠を指すが、両者が混合したものを使用してもよい。な
お、有効成分は、熱および光に対して安定であるため、上記の原料は、浸漬、蒸煮、焙煎
(砂焙り、網焙り、熱風焙煎等全てを指す)、蒸煮焙煎、凍結乾燥等の表面変性、UV照
射等の光変性、パットライス等の加圧焙煎、揚げる等の原料処理をしてもよい。白米、玄
米及び発芽させた米は、そのまま用いても有効であるが、実用上の面から粉砕して用いる
のが好ましい。白米、玄米及び発芽させた米を粉砕して粉体化するには、粉砕機または精
米機を用い一般的な方法で行なえばよい。
The “rice” according to the present invention is a concept including not only rice such as white rice, brown rice and germinated rice, but also part of rice such as white rice and red rice bran. However, the rice must contain a white rice portion, that is,
It is preferable to use white rice, brown rice, germinated rice, and white birch. Here, regarding white rice and brown rice, it refers to brown rice and white rice such as sticky rice and brown rice, regardless of japonica and indica rice, and any kind and kind. In addition, white shark and red shark generally appear at the time of whitening.
Although it indicates 2% or more of red cocoon and 92% or less of white cocoon, a mixture of both may be used. In addition, since the active ingredient is stable to heat and light, the above-mentioned raw materials are dipping, steaming, roasting (pointing to all of sand roasting, net roasting, hot air roasting, etc.), steaming roasting, freeze drying It may be subjected to raw material treatment such as surface modification such as UV irradiation, photo-modification such as UV irradiation, pressure roasting such as Patrice, frying. White rice, brown rice, and germinated rice are effective when used as they are, but are preferably pulverized for practical use. In order to pulverize white rice, brown rice and germinated rice into powder, a general method may be used using a pulverizer or a rice mill.
発芽させた米を製造する場合、胚芽のついた米を水に浸漬あるいは水を噴霧して発芽さ
せる。発芽させる時の温度は5〜70℃である。ただし、発芽さえすれば、温度および時
間は問わない。また、発芽中に水が腐敗する危険性がある場合は、腐敗しないように水を
取り替えるか、何らかの防腐を行うのが好ましい。ここで、発芽とは、発芽する直前から
発芽したものまで全てを指す。この発芽させた米をよく洗浄して用いる。この時、乾燥し
て用いてもよい。米を抽出、あるいは酵素分解または麹を作用させる場合、原料の米を粉
砕して顆粒あるいは粉体化すると、表面積が大きくなるため効率がよくなる。粉砕しなく
てもよいが、この場合には、米組織の分解および抽出に長時間を要する。
In the case of producing germinated rice, germinated rice is immersed in water or sprayed with water. The temperature at the time of germination is 5-70 degreeC. However, the temperature and time are not limited as long as germination occurs. In addition, when there is a risk of water rot during germination, it is preferable to replace the water so that it does not rot or to perform some preservative. Here, germination refers to everything from just before germination to germination. The germinated rice is washed thoroughly before use. At this time, you may dry and use. When rice is extracted, or enzymatically decomposed or subjected to koji, the raw material rice is pulverized into granules or powders, so that the surface area is increased and the efficiency is improved. Although it is not necessary to grind, in this case, it takes a long time to decompose and extract the rice tissue.
米を水抽出する場合、抽出温度は、高温が効率的であるが、低温でも十分に抽出を行う
ことができる。ただし、40℃以下の低温の場合は、pHを酸性あるいはアルカリ性にする
か、防腐剤あるいはアルコールを加えて、米が腐敗しないように処理することが望ましい
。抽出時間は、有効成分さえ抽出できれば、長くても短くてもよく、抽出温度により定め
ればよい。また、抽出は、加圧下または常圧下で行っても、減圧下で行ってもよい。水抽
出の場合、最も問題になるのは糊化現象である。糊状になれば、抽出効率が悪くなるばか
りでなく、実作業においては困難を極める。これを防ぐためには、アミラーゼを加えて反
応させるか、塩酸などで酸性にして澱粉を切ってやればよく、この方法を用いることによ
り、十分に解決でき、実用上も全く問題はない。
When water is extracted from rice, a high extraction temperature is efficient, but extraction can be sufficiently performed even at a low temperature. However, in the case of a low temperature of 40 ° C. or lower, it is desirable that the pH is made acidic or alkaline, or a preservative or alcohol is added so that the rice is not spoiled. The extraction time may be long or short as long as the active ingredient can be extracted, and may be determined by the extraction temperature. The extraction may be performed under pressure, normal pressure, or reduced pressure. In the case of water extraction, the most serious problem is the gelatinization phenomenon. If it becomes paste-like, not only extraction efficiency will worsen but it will be extremely difficult in actual work. In order to prevent this, the reaction may be performed by adding amylase or acidifying with hydrochloric acid or the like to cut the starch. By using this method, the problem can be solved sufficiently and there is no problem in practical use.
抽出物中の有効成分は、酸,アルカリに安定であるためか、酸分解抽出、あるいはアル
カリ分解抽出を行うのも有効である。この場合、必要により中和、脱塩を行う。有機溶媒
で抽出する場合も、米はなるべく微粉砕または粉体化して抽出することが望ましい。有機
溶媒はアルコール,アセトン,n−ヘキサン,メタノール等の一般的な有機溶媒でよいが
、人体に対して有害なものは抽出後、溶媒を完全に除去する必要があるので安全なものが
よい。また、米を酵素分解、または麹を作用させてもよい。ここで言う酵素分解とは、澱
粉分解酵素(液化酵素、糖化酵素),蛋白分解酵素,脂肪分解酵素,繊維分解酵素,リグ
ニン分解酵素,ペクチン分解酵素等米に働く酵素を1種または2種以上作用させることを
いう。例えば、液化酵素と糖化酵素との組み合わせを挙げることができる。また、麹とし
て麹菌の種類および米の品種,種類は問わない。
It is also effective to perform acid decomposition extraction or alkali decomposition extraction because the active ingredient in the extract is stable to acid and alkali. In this case, neutralization and desalting are performed as necessary. Also when extracting with an organic solvent, it is desirable to extract rice by pulverizing or pulverizing it as much as possible. The organic solvent may be a common organic solvent such as alcohol, acetone, n-hexane, methanol or the like, but those which are harmful to the human body are preferably safe because the solvent needs to be completely removed after extraction. In addition, rice may be enzymatically degraded, or rice bran may be allowed to act. Enzymatic degradation here refers to one or more enzymes that act on rice, such as starch degrading enzymes (liquefaction enzymes, saccharifying enzymes), proteolytic enzymes, lipolytic enzymes, fiber degrading enzymes, lignin degrading enzymes, pectin degrading enzymes. It means to act. For example, the combination of a liquefying enzyme and a saccharifying enzyme can be mentioned. In addition, the type of koji mold and the variety and type of rice are not questioned.
さらに、前記の抽出を行うに当り、抽出の前、抽出と同時または抽出の後に、上記の酵
素分解および麹を作用させてもよい。本発明においては、さらに上記の処理を行なうと同
時または処理後、アルコール発酵あるいは乳酸発酵、酢酸発酵等の有機酸発酵を行うと、
次のような点でも有効である。アルコール発酵を行なえば、塗布時にベタツキがないばか
りか、濃縮がしやすく、有効成分の濃縮が容易になる。なお、酵母による通気発酵、アル
コール沈澱等を行なって除糖してもよい。
Furthermore, in performing the said extraction, you may make said enzyme decomposition | disassembly and soot act before extraction, simultaneous with extraction, or after extraction. In the present invention, when the above treatment is further performed or simultaneously after the treatment, alcohol fermentation or lactic acid fermentation, and organic acid fermentation such as acetic acid fermentation,
The following points are also effective. When alcoholic fermentation is performed, not only is there no stickiness at the time of application, but it is easy to concentrate and the active ingredient is easily concentrated. The sugar may be removed by aeration fermentation with yeast, alcohol precipitation, or the like.
本発明に係る寿命延長剤を用いると、生命体の寿命や細胞の寿命が延長される。ここで
、生命体とは、単細胞生物だけでなく、多細胞生物(ヒトを含む哺乳類といった高等動物
も含む)も含む概念である。また、細胞も、単細胞に限られず、複数の細胞から成り立つ
、器官、臓器、組織、体液等も包含する概念である。
When the life extension agent according to the present invention is used, the life of a living organism or the life of a cell is extended. Here, a living organism is a concept that includes not only single-celled organisms but also multicellular organisms (including higher animals such as mammals including humans). In addition, the cell is not limited to a single cell, but is a concept including organs, organs, tissues, body fluids, and the like that are composed of a plurality of cells.
以上のようにして得られた本発明品は、残渣を分離することなくそのまま、あるいは圧
搾、濾過して用いる。そのまま用いるときは、殺菌あるいは除菌をして製品にする。なお
、本発明品を外用剤として用いる場合には、実際の用途に応じ、常法にしたがってクリー
ム、洗顔料、乳液、化粧水、クレンジング、パック、石鹸などの化粧料、軟膏剤、パスタ
剤、ローション剤、チンキ剤、リエメント剤、ゼリー剤、エアゾール剤などの剤型にする
。また、軟カプセル剤、硬カプセル剤、錠剤、シロップ剤などの経口剤、注射剤等の剤型
で用いることもできる。更には、食品や飲料に添加する処方もあり得る。尚、用途に応じ
、他の配合成分や薬剤を添加してもよい。
The product of the present invention obtained as described above is used as it is, or after being squeezed and filtered without separating the residue. When it is used as it is, it is sterilized or sterilized to make a product. When the product of the present invention is used as an external preparation, cosmetics such as cream, face wash, emulsion, lotion, cleansing, pack, soap, etc., ointment, pasta, Use lotions, tinctures, ligaments, jellies, aerosols and other dosage forms. Moreover, it can also be used in dosage forms such as soft capsules, hard capsules, tablets, syrups and other oral preparations, and injections. Furthermore, there may be a prescription added to foods and beverages. In addition, you may add another compounding component and a chemical | medical agent according to a use.
また、本発明に係る寿命延長剤は、様々な具体的用途に有用である。例えば、臓器移植
などにおける、臓器保存液や細胞保存液等の使用;血液への使用;生命体或いは個体、器
官、臓器、組織、体液又は細胞などの機能の向上又は改善、正常化、健全化、老化防止、
若々しさ保持或いは若返り;循環器系(心臓、血管、血液・造血器系)、免疫系(リンパ
性組織・器官、脾臓、胸腺)、皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、
胃、小腸、大腸、肝臓、胆管系、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿
器系(腎臓、尿路)、性殖系(男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、
甲状腺、副腎)、脳、神経系(末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、
平衡・聴覚器、視覚器、各粘膜系、運動器(骨、関節、筋肉、腱、靱帯)などの機能の向
上又は改善、正常化、健全化、老化防止、若々しさ保持或いは若返り;生命体或いは個体
、器官、臓器、組織、体液又は細胞などにおける疾患及び諸症状の予防、改善、治療;循
環器系(心臓、血管、血液・造血器系)、免疫系(リンパ性組織・器官、脾臓、胸腺)、
皮膚、皮膚付属器官、消化器系(口唇、扁桃、歯、食道、胃、小腸、大腸、肝臓、胆管系
、脾臓)、呼吸器系(鼻、咽頭、喉頭、気管、肺)、泌尿器系(腎臓、尿路)、性殖系(
男性生殖器、女性生殖器)、内分泌系(下垂体、松果体、甲状腺、副腎)、脳、神経系(
末梢神経、中枢神経)、代謝系(糖、脂質、尿酸代謝)、平衡・聴覚器、視覚器、各粘膜
系、運動器(骨、関節、筋肉、腱、靱帯)などにおける疾患及び諸症状の予防、悪化防止
、改善、治療;表皮・真皮に起因する皮膚障害、細胞障害、DNA障害、アトピー性皮膚
炎、ドライスキンなどの乾燥性皮膚症状(アトピー皮膚、乾燥・ソゾウ化皮膚、老化皮膚
、魚鱗癬、かさかさ肌、荒れ肌、皮脂欠乏症、乾皮症、乾燥性湿疹、進行性手掌角皮症、
紅斑、硬化・角化、亀裂、鱗屑、紋理、痒み、掻瘢痕)、シミ、ソバカス、掻痒症、あせ
も、荒れ性、しもやけ、ひび、あかぎれ、皮膚老化症状(しわ、ハリ・弾力の低下、たる
み、シミ)、油性肌、ニキビ、色素異常症、紫外線による皮膚障害(シミ、ソバカス)、
光炎症、くすみ、黒ずみ、物理・化学的皮膚障害(切り傷、火傷、床ずれ)、水、石けん
、洗剤、界面活性剤、溶媒の使用により引き起こされる皮膚症状、皮膚外用剤などの医薬
品の副作用、生物的皮膚障害(皮膚感染症)、水虫、皮膚炎、湿疹、創傷治癒、育毛、養
毛、発毛、脱毛症、の予防、改善、治療;シミ、ソバカス、老人性色素斑の予防、改善、
治療である場合;各種炎症、感染症、アレルギー、免疫機能障害、粘膜障害、細胞障害、
DNA障害、腫瘍、潰瘍、高脂血症、肥満、糖尿病、動脈硬化、痛風、血圧の健全化、改
善(高血圧、低血圧)ボケ、痴呆症、鼻炎、喘息、目の諸症状、風邪、血管障害、うちみ
、肩こり、くじき、神経痛、腰痛、リウマチ、痔、疲労回復、産前産後の冷え症、口内炎
、のどの炎症、痛み、咽頭炎、喉頭炎、扁桃炎、歯周炎、歯槽膿漏、歯肉炎、骨粗鬆症、
滋養強壮、虚弱体質、肉体疲労、体力低下、塩害防止、ヘリコバクターピロリ生育阻止、
ストレス、医薬品による副作用の予防、改善、治療;腫瘍の予防、悪化防止、改善、治療
が、癌予防、悪化防止、進行抑制、転移防止、改善、治療である場合;性機能の向上、改
善、悪化防止、正常化、健全化又は老化防止、若々しさ保持或いは若返り;生命体又は、
個体、器官、臓器、組織、体液、細胞などの保存、鮮度保持、を挙げることができる。尚
、前記の「鮮度保持」に関しては、例えばヒトに対する効果だけでなく、魚(生魚を含む
)、生花、及び肉、魚、野菜などの生鮮食品においても鮮度保持効果をもつ。尚、上記の
かっこ書きは、例として挙げたものであり、これらに限られるものではない。
Moreover, the lifetime extension agent which concerns on this invention is useful for various specific uses. For example, use of organ preservation solution or cell preservation solution in organ transplantation, etc .; use in blood; improvement or improvement, normalization, and restoration of functions of living organisms or individuals, organs, organs, tissues, body fluids or cells Anti-aging,
Youthfulness retention or rejuvenation; circulatory system (heart, blood vessel, blood / hematopoietic system), immune system (lymphoid tissue / organ, spleen, thymus), skin, skin appendages, digestive system (lip, tonsils, Teeth, esophagus,
Stomach, small intestine, large intestine, liver, bile duct system, spleen), respiratory system (nose, pharynx, larynx, trachea, lung), urinary system (kidney, urinary tract), sex breeding system (male genital organ, female genital organ), endocrine System (pituitary gland, pineal gland,
Thyroid, adrenal gland), brain, nervous system (peripheral nerve, central nervous system), metabolic system (sugar, lipid, uric acid metabolism),
Improving or improving functions of balance / auditor, visual organ, mucosal system, motor organs (bone, joint, muscle, tendon, ligament), normalization, restoration, prevention of aging, preserving youthfulness or rejuvenation; life Prevention, improvement, treatment of diseases and symptoms in the body or individuals, organs, organs, tissues, body fluids or cells; cardiovascular system (heart, blood vessel, blood / hematopoietic system), immune system (lymphoid tissue / organ, Spleen, thymus),
Skin, skin appendages, digestive system (lips, tonsils, teeth, esophagus, stomach, small intestine, large intestine, liver, bile duct, spleen), respiratory system (nose, pharynx, larynx, trachea, lungs), urinary system ( Kidney, urinary tract), sex breeding system (
Male and female genitalia), endocrine system (pituitary gland, pineal gland, thyroid, adrenal gland), brain, nervous system (
Peripheral nerve, central nerve), metabolic system (sugar, lipid, uric acid metabolism), balance / hearing device, visual organ, each mucosal system, motor organs (bone, joint, muscle, tendon, ligament), etc. Prevention, prevention of deterioration, improvement, treatment; skin disorders caused by epidermis / dermis, cell disorders, DNA disorders, atopic dermatitis, dry skin symptoms such as dry skin (atopy skin, dry / sozoized skin, aging skin, Ichthyosis, bulky skin, rough skin, sebum deficiency, xeroderma, dry eczema, progressive palmokeratosis,
Erythema, sclerosis / keratinization, cracks, scales, itchy, itching, scarring), spots, buckwheat, pruritus, skin rash, roughness, moistness, cracks, redheads, skin aging symptoms (wrinkles, reduced elasticity, sagging, sagging, Stains), oily skin, acne, pigmentation disorders, skin damage caused by ultraviolet rays (stains, buckwheat),
Photoinflammation, dullness, darkening, physical / chemical skin disorders (cuts, burns, bedsores), water, soaps, detergents, surfactants, skin effects caused by the use of solvents, side effects of pharmaceuticals such as external preparations for skin, biological Prevention, improvement, treatment of static skin disorders (skin infections), athlete's foot, dermatitis, eczema, wound healing, hair growth, hair restoration, hair growth, alopecia; prevention, improvement of spots, buckwheat, senile pigment spots,
In the case of treatment; various inflammations, infections, allergies, immune dysfunction, mucosal disorders, cell disorders,
DNA disorder, tumor, ulcer, hyperlipidemia, obesity, diabetes, arteriosclerosis, gout, blood pressure restoration, improvement (hypertension, hypotension) blur, dementia, rhinitis, asthma, eye symptoms, cold, blood vessels Disability, internal stiffness, stiff shoulders, lottery, neuralgia, low back pain, rheumatism, hemorrhoids, recovery from fatigue, prepartum cold disease, stomatitis, throat inflammation, pain, sore throat, laryngitis, tonsillitis, periodontitis, alveolar effusion, gingiva Flame, osteoporosis,
Nourishing tonic, frail constitution, physical fatigue, physical fitness decline, salt damage prevention, Helicobacter pylori growth inhibition,
Prevention, improvement, treatment of side effects caused by stress and pharmaceuticals; When tumor prevention, prevention of deterioration, improvement, treatment is cancer prevention, prevention of deterioration, progression suppression, prevention of metastasis, improvement, treatment; improvement of sexual function, improvement, Deterioration prevention, normalization, restoration or prevention of aging, preserving youthfulness or rejuvenation;
Examples include preservation of an individual, organ, organ, tissue, body fluid, cell, etc., and maintaining freshness. Note that the “freshness preservation” has not only an effect on humans, but also freshness preservation effects in fish (including raw fish), fresh flowers, and fresh foods such as meat, fish, and vegetables. Note that the above parentheses are given as examples and are not limited thereto.
実施例1
白米を粉砕機にかけ、白米の粉砕物500gを得た。この粉砕物に澱粉分解酵素10g
と水1500mLを添加した。その後、徐々に温度を上げていき5分間煮沸抽出した後、冷
却した。その後、絞り機で絞り、本発明品を得た。
Example 1
The white rice was put into a pulverizer to obtain 500 g of pulverized white rice. 10g of starch-degrading enzyme
And 1500 mL of water were added. Thereafter, the temperature was gradually raised, boiling and extracting for 5 minutes, and then cooled. Then, it squeezed with the squeezer and obtained the product of the present invention.
実施例2
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物に米麹300gと水15
00mLを添加し、55℃で20時間放置した。その後絞り機で絞り、本発明品を得た。
Example 2
White rice was pulverized to obtain 500 g of pulverized white rice. 300 g of rice bran and water 15
00 mL was added and left at 55 ° C. for 20 hours. Thereafter, the product was squeezed with a squeezer to obtain the product of the invention.
実施例3
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物にタンパク質分解酵素2
g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと
水1500mLを添加し、50℃で20時間放置した。その後徐々に温度を上げていき5分
間煮沸抽出した後冷却した。この酵素分解抽出物に酵母を添加し、7日間アルコール発酵
した。その後、絞り機で絞り、本発明品を得た。
Example 3
White rice was pulverized to obtain 500 g of pulverized white rice. Proteolytic enzyme 2
g, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1500 mL of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised and the mixture was boiled and extracted for 5 minutes and then cooled. Yeast was added to this enzymatic degradation extract, and alcohol fermentation was performed for 7 days. Then, it squeezed with the squeezer and obtained the product of the present invention.
実施例4
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物にタンパク質分解酵素2
g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと
水1500mLを添加し、50℃で20時間放置した。その後徐々に温度を上げていき5分
間煮沸抽出した後冷却した。この酵素分解抽出物に乳酸菌を添加し、2日間乳酸発酵した
。その後、絞り機で絞り、本発明品を得た。
Example 4
White rice was pulverized to obtain 500 g of pulverized white rice. Proteolytic enzyme 2
g, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1500 mL of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised and the mixture was boiled and extracted for 5 minutes and then cooled. Lactic acid bacteria were added to this enzymatic degradation extract, and lactic acid fermentation was performed for 2 days. Then, it squeezed with the squeezer and obtained the product of the present invention.
実施例5
実施例1で得た米エキス1500mLに乳酸菌を添加し、2日間乳酸発酵を行った。その
後、濾過器で乳酸菌を濾別し、本発明品を得た。
Example 5
Lactic acid bacteria were added to 1500 mL of the rice extract obtained in Example 1, and lactic acid fermentation was performed for 2 days. Thereafter, lactic acid bacteria were filtered off with a filter to obtain a product of the present invention.
実施例6
実施例2で得た米エキス1500mLに酵母を添加し、7日間アルコール発酵を行った。
その後、濾過器で酵母を濾別し、本発明品を得た。
Example 6
Yeast was added to 1500 mL of the rice extract obtained in Example 2, and alcohol fermentation was performed for 7 days.
Thereafter, the yeast was separated by a filter to obtain the product of the present invention.
実施例7
胚芽のついたままの米1kgを30℃の水につけ3日間浸漬、吸水させ、米を発芽させ
た。この発芽米をよく洗浄した後、50℃で24時間乾燥し、その後細かく微粉砕し、本
発明品950gを得た。
Example 7
1 kg of rice with germs attached was soaked in water at 30 ° C. for 3 days to absorb water and germinate the rice. The germinated rice was thoroughly washed, dried at 50 ° C. for 24 hours, and then finely pulverized to obtain 950 g of the product of the present invention.
実施例8
実施例7で得られた発芽米の粉砕物500gに澱粉分解酵素10gと水1500mLを添
加した。その後徐々に温度を上げていき、酵素を作用させた後、5分間煮沸抽出し、冷却
した。抽出物を絞り機で絞り、本発明品1420mLと残渣500gを得た。
Example 8
10 g of amylolytic enzyme and 1500 mL of water were added to 500 g of the ground product of the germinated rice obtained in Example 7. Thereafter, the temperature was gradually raised and the enzyme was allowed to act, followed by boiling extraction for 5 minutes and cooling. The extract was squeezed with a squeezer to obtain 1420 mL of the product of the present invention and 500 g of residue.
実施例9
玄米を粉砕機にかけよく粉砕し、玄米の粉砕物500gを得た。この粉砕物に水150
0mLと麹300gを加え、55℃で20時間放置した。その後、絞り機で絞り、本発明品
1500mLと残渣700gを得た。
Example 9
Brown rice was pulverized well with a pulverizer to obtain 500 g of pulverized brown rice. Water 150
0 mL and 300 g of sputum were added, and the mixture was left at 55 ° C. for 20 hours. Thereafter, the product was squeezed with a squeezer to obtain 1500 mL of the product of the present invention and 700 g of residue.
実施例10
玄米を粉砕機にかけ、玄米の粉砕物500gを得た。この粉砕物に蛋白分解酵素2g、
脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと水1
500mLを加え、50℃で24時間放置した。その後酵母を添加し、16日間アルコ−ル
発酵した。その後、絞り機で絞り、本発明品1600mLと残渣300gを得た。
Example 10
Brown rice was put into a pulverizer to obtain 500 g of pulverized brown rice. 2 g of proteolytic enzyme is added to this pulverized product,
2 g lipolytic enzyme, 2 g fiber degrading enzyme, 2 g starch degrading enzyme, 2 g pectin degrading enzyme and water 1
500 mL was added and left at 50 ° C. for 24 hours. Thereafter, yeast was added and alcohol fermentation was performed for 16 days. Then, it squeezed with the squeezer and obtained 1600 mL of this invention products and 300 g of residue.
実施例11
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物にタンパク質分解酵素2
g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと
水1500mLを添加し、50℃で20時間放置した。その後徐々に温度を上げていき5分
間煮沸抽出した後冷却した。抽出物を絞り機で絞り、本発明品1470mLと残渣450g
を得た。
Example 11
White rice was pulverized to obtain 500 g of pulverized white rice. Proteolytic enzyme 2
g, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1500 mL of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised and the mixture was boiled and extracted for 5 minutes and then cooled. The extract is squeezed with a squeezer, 1470 mL of the present product and 450 g of residue.
Got.
実施例12
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物に澱粉分解酵素10gと
水1500mLを添加した。その後徐々に温度を上げていき、酵素を作用させた後、5分間
煮沸抽出し、冷却した。抽出物を絞り機で絞り、本発明品1420mLと残渣500gを得
た。
Example 12
White rice was pulverized to obtain 500 g of pulverized white rice. To this pulverized product, 10 g of amylolytic enzyme and 1500 mL of water were added. Thereafter, the temperature was gradually raised and the enzyme was allowed to act, followed by boiling extraction for 5 minutes and cooling. The extract was squeezed with a squeezer to obtain 1420 mL of the product of the present invention and 500 g of residue.
実施例13
白米を粉砕機にかけ白米の粉砕物500gを得た。この粉砕物に澱粉分解酵素10gと
水1500mLを添加した。その後徐々に温度を上げていき、5分間煮沸抽出し、冷却した
。この抽出物にタンパク質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分
解酵素2g、ペクチン分解酵素2gを添加し、50℃で24時間放置した。その後絞り機
で絞り、本発明品1500mLと残渣400gを得た。
Example 13
White rice was pulverized to obtain 500 g of pulverized white rice. To this pulverized product, 10 g of amylolytic enzyme and 1500 mL of water were added. The temperature was then gradually raised, boiled and extracted for 5 minutes, and cooled. To this extract, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme and 2 g of pectin degrading enzyme were added and left at 50 ° C. for 24 hours. Thereafter, the product was squeezed with a squeezer to obtain 1500 mL of the present product and 400 g of a residue.
実施例14
玄米を粉砕機にかけ、玄米の粉砕物500gを得た。この粉砕物に澱粉分解酵素10g
と水1500mLを添加した。その後、徐々に温度を上げていき、酵素を作用させた後、5
分間煮沸抽出し、冷却した。これにに95%エタノール100mLを添加し、20日間酢酸
発酵を行った。その後ろ過し、本発明品1400mLを得た。
Example 14
Brown rice was put into a pulverizer to obtain 500 g of pulverized brown rice. 10g of starch-degrading enzyme
And 1500 mL of water were added. After that, gradually raise the temperature, let the enzyme act,
Boiled for min and cooled. To this, 100 mL of 95% ethanol was added, and acetic acid fermentation was performed for 20 days. Thereafter, filtration was performed to obtain 1400 mL of the present product.
実施例15
精白歩合50〜70%の特白糠490g、92%以上の赤糠10gに、蛋白分解酵素2
g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと
水1500mLを加え、50℃で20時間放置した。その後、徐々に温度を上げていき、5
分間煮沸抽出した後、30℃まで冷却し、絞り機で絞り、本発明品1400mLと残渣55
0mLを得た。
Example 15
The proteolytic enzyme 2 is added to 490 g of white koji with a polishing rate of 50-70% and 10 g of red koji with a purity of 92% or more.
g, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1500 mL of water, and left at 50 ° C. for 20 hours. Then gradually increase the temperature.
After boiling and extracting for 30 minutes, it is cooled to 30 ° C. and squeezed with a squeezer, 1400 mL of the present product and residue 55
0 mL was obtained.
実施例16
実施例10で得られた残渣300gに60℃の温水500mLを加え、よく攪拌して45
℃に調整し、その温度を保ちながら5時間放置した。その後徐々に加温し、5分間煮沸抽
出し、冷却した。抽出物を絞り機で絞り、本発明品480mLを得た。
Example 16
To 300 g of the residue obtained in Example 10, add 500 mL of warm water at 60 ° C.
The temperature was adjusted to 0 ° C. and left for 5 hours while maintaining the temperature. Thereafter, the mixture was gradually heated, boiled and extracted for 5 minutes, and cooled. The extract was squeezed with a squeezer to obtain 480 mL of the product of the present invention.
試験例1
方法:コンフルエントに培養した小腸粘膜上皮細胞(IEC−6)に、1%試料を添加し
た培養液で30日間培養した。各試料1%添加後、培地交換は行わなかった。
試料:実施例1〜実施例6。なお、実施例3、実施例6は、ロータリーエバポレーターで
減圧濃縮し、アルコール分を溜去した後、水を加え、もとの量に戻したものを試料として
用いた。
結果:各試料1%を添加し、30日間培養した後のIEC−6を肉眼的に観察した結果、
異常が全く認められず、正常な状態を維持し生存し続けていることが判明した。また、そ
の細胞は若々しかった。一方、試料を添加しなかった細胞では、生存し続けることができ
なかった。以上の試験から本発明品による寿命延長効果が実証された。また、老化防止、
若々しさ保持効果も認められた。
Test example 1
Method: Intestinal mucosal epithelial cells (IEC-6) cultured confluently were cultured in a culture medium supplemented with a 1% sample for 30 days. The medium was not changed after adding 1% of each sample.
Sample: Example 1 to Example 6. In Examples 3 and 6, the sample was concentrated under reduced pressure using a rotary evaporator, the alcohol was distilled off, water was added, and the amount returned to the original amount was used as a sample.
Results: As a result of macroscopic observation of IEC-6 after adding 1% of each sample and culturing for 30 days,
No abnormalities were observed, and it was found that they remained normal and remained alive. The cells were young. On the other hand, the cells to which no sample was added could not continue to survive. From the above test, the life extension effect by the product of the present invention was proved. It also prevents aging,
A youthfulness retention effect was also observed.
試験例2
方法:コンフルエントに培養した胃粘膜上皮細胞(RGM−1)に、3%エタノール、及
び、各試料1%を添加した培養液で培養し、RGM−1の生存活性をWST−1アッセイ
にて評価した。また、米エキスの細胞障害抑制効果を培養液中のLDH releaseを測定す
ることにより評価した。
試料:実施例1
結果:図1及び図2に示すとおり、試料1%を添加することにより、RGM−1の生存活
性の亢進、細胞機能の向上、改善、正常化、健全化及び細胞障害予防効果が認められた。
Test example 2
Method: Gastric mucosal epithelial cells (RGM-1) cultured confluently were cultured in a culture solution containing 3% ethanol and 1% of each sample, and the survival activity of RGM-1 was evaluated by WST-1 assay. did. Moreover, the cytopathic inhibitory effect of the rice extract was evaluated by measuring LDH release in the culture solution.
Sample: Example 1
Results: As shown in FIGS. 1 and 2, by adding 1% of the sample, the RGM-1 survival activity was enhanced, the cell function was improved, improved, normalized, soundened, and cytotoxicity-preventing effects were observed. .
試験例3
方法:コンフルエントに単層培養した胃粘膜上皮細胞(RGM−1)に、直径1mmの円形
の細胞欠損部位を作成し、3%エタノール及び1%試料を添加した培養液で培養した。経
時的に欠損部位の面積を測定することにより損傷修復効果を評価した。
試料:実施例1
結果:表1に示すとおり、試料1%を添加することにより、細胞障害が速やかに修復され
、細胞増殖亢進、損傷修復促進効果が認められた。
以上の試験より、本発明品による細胞障害の正常化、健全化、改善、治癒効果が実証され
た。
Test example 3
Method: A gastric mucosal epithelial cell (RGM-1) cultured confluently in a single layer was formed into a circular cell defect site with a diameter of 1 mm, and cultured in a culture medium supplemented with 3% ethanol and 1% sample. The damage repair effect was evaluated by measuring the area of the defect site over time.
Sample: Example 1
Results: As shown in Table 1, by adding 1% of the sample, cell damage was quickly repaired, and cell growth enhancement and damage repair promoting effects were observed.
From the above test, normalization, improvement, improvement, and healing effect of cell damage by the product of the present invention were demonstrated.
試験例1〜3より、本発明品には、寿命延長、若返り、若々しさの保持、老化防止、機
能の向上、改善、正常化、健全化、障害の予防、改善、悪化防止、治療効果が認められた
。また、細胞機能、細胞活性、細胞周期、遺伝子機能を正常に調節する、より良い状態に
調節する効果をもつことも明らかとなった。なお、癌化を促進するものではなかった。
From Test Examples 1 to 3, the product of the present invention has a life extension, rejuvenation, retention of youthfulness, prevention of aging, improvement of function, improvement, normalization, restoration, prevention of failure, improvement, prevention of deterioration, therapeutic effect Was recognized. In addition, it has been revealed that it has the effect of regulating cell function, cell activity, cell cycle, and gene function normally, and in a better condition. It did not promote canceration.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005095222A JP4772354B2 (en) | 2005-03-29 | 2005-03-29 | Life extension agent made from rice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005095222A JP4772354B2 (en) | 2005-03-29 | 2005-03-29 | Life extension agent made from rice |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004000636 Division | 2004-01-05 | 2004-01-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005194289A JP2005194289A (en) | 2005-07-21 |
JP2005194289A5 JP2005194289A5 (en) | 2007-08-30 |
JP4772354B2 true JP4772354B2 (en) | 2011-09-14 |
Family
ID=34824921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005095222A Expired - Lifetime JP4772354B2 (en) | 2005-03-29 | 2005-03-29 | Life extension agent made from rice |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4772354B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4008486B2 (en) * | 2005-07-04 | 2007-11-14 | 孝仁 徳山 | Organ preservatives made from white rice |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0741426A (en) * | 1993-05-25 | 1995-02-10 | Soken Kk | Active oxygen scavenger from rice |
JP3795541B2 (en) * | 1993-11-12 | 2006-07-12 | 株式会社創研 | Lipid peroxide inhibitor from rice |
-
2005
- 2005-03-29 JP JP2005095222A patent/JP4772354B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2005194289A (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4889093B2 (en) | Sponge-based therapeutic compositions for the treatment and prevention of skin diseases | |
JP6670166B2 (en) | Cosmetics | |
JP6969067B2 (en) | Anti-inflammatory, anti-aging and whitening agents | |
KR20190116837A (en) | Composition Comprising Radish Extract for Improving Skin Wrinkle and Elasticity | |
CN106721855A (en) | A kind of solid beverage preparation method for safeguarding men's health | |
JPH0741426A (en) | Active oxygen scavenger from rice | |
CN108186542A (en) | Lip care lipstick with antiallergic effect of releiving | |
CN109259022A (en) | A kind of drink containing small-molecular peptides that can quickly improve microcirculation function | |
KR101063544B1 (en) | Cosmetic composition and preparation method thereof | |
JP3811198B2 (en) | Antiallergic agent from rice | |
JP4772354B2 (en) | Life extension agent made from rice | |
JP6159918B2 (en) | Hyaluronidase inhibitors and methods for inhibiting hyaluronidase activity | |
JPH08119870A (en) | Agent for normalizing turn over from rice | |
CN105878152A (en) | Pasty bath salt containing punica granatum fruit extract | |
JP2019178123A (en) | Glycyrrhiza extract fermented product, whitening agent, anti-aging agent, skin cosmetic and food and drink | |
JP5307969B2 (en) | Life extension agent containing white rice-derived ingredients as active ingredients | |
JP2006219431A (en) | Composition having rough skin-preventing activity, cosmetic and beverage | |
JP5514390B2 (en) | Life extension agent made from cereals and beans other than rice | |
CN1698579A (en) | Caring composition with facial beautification and skin rejuvenation function | |
JP5296957B2 (en) | Anti-aging agent for oral use | |
JP5937450B2 (en) | Hyaluronidase inhibitor | |
KR20210066537A (en) | A composition for improving skin beauty containing glycosaminoglycan extracted from insect | |
JP7253283B2 (en) | Cosmetics and Food and Beverage Compositions | |
CN107875059A (en) | A kind of composition with acne-removing | |
CN107822979A (en) | A kind of preparation method of the freeze-dried powder of the composition with acne-removing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070717 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100518 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100716 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100817 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101124 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20101228 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110315 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110322 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110614 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110622 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140701 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4772354 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |